Valuation Beam Therapeutics Inc.

Stocks

Market Closed - Nasdaq Other stock markets 21:00:00 11/06/2026 BST			5-day change	1st Jan Change
29.41 ^USD	-0.27%		-0.47%	+6.10%

05-25	Beam Therapeutics Inc. Presents at RBC Capital Markets Global Healthcare Conference 2026, May-20-2026 10:30 AM
05-18	Beam Therapeutics Inc. Presents Topline Clinical Data for BEAM-302 in Alpha-1 Antitrypsin Deficiency At American Thoracic Society International Conference	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	5,327	2,692	2,159	1,974	2,736	2,935	-	-
Change	-	-49.47%	-19.78%	-8.58%	38.6%	7.29%	-	-
Enterprise Value (EV) ¹	4,367	1,613	969.4	1,974	2,441	2,081	1,764	2,144
Change	-	-63.05%	-39.92%	103.62%	23.66%	-14.75%	-15.25%	21.56%
P/E Ratio	-13.8x	-9.47x	-15.8x	-5.41x	-34.2x	-6.72x	-6.44x	-6.99x
PBR	6.19x	3.66x	2.14x	2.83x	2.28x	3.62x	3.25x	4.93x
PEG	-	0.3x	0.3x	-0x	0.4x	-0x	-1.48x	0.9x
Capitalization / Revenue	103x	44.2x	5.72x	31.1x	19.6x	40.1x	33.6x	20.5x
EV / Revenue	84.2x	26.5x	2.57x	31.1x	17.5x	28.4x	20.2x	15x
EV / EBITDA	-11.3x	-4.97x	-6.2x	-5.01x	-6.75x	-4.39x	-3.43x	-4.4x
EV / EBIT	-11.1x	-4.77x	-5.49x	-4.75x	-6.36x	-4.17x	-3.24x	-3.88x
EV / FCF	-38.6x	-61.1x	-5.3x	-5.54x	-6.78x	-4.91x	-4.27x	-6.15x
FCF Yield	-2.59%	-1.64%	-18.9%	-18%	-14.8%	-20.4%	-23.4%	-16.3%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	-5.77	-4.13	-1.72	-4.58	-0.81	-4.387	-4.578	-4.222
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	51.84	60.92	377.7	63.52	139.7	73.19	87.27	143.1
EBITDA ¹	-385	-324.3	-156.5	-393.6	-361.4	-473.7	-514.1	-487.7
EBIT ¹	-392.5	-338.5	-176.5	-415.6	-383.7	-499.5	-543.6	-552.9
Net income ¹	-370.6	-289.1	-132.5	-376.7	-79.99	-464.8	-520.6	-508.8
Net Debt ¹	-960.4	-1,078	-1,190	-	-294.9	-854.5	-1,172	-791.7
Reference price ²	79.69	39.11	27.22	24.80	27.72	29.49	29.49	29.49
Nbr of stocks (in thousands)	66,849	68,821	79,326	79,592	98,693	99,537	-	-
Announcement Date	28/02/22	28/02/23	27/02/24	25/02/25	24/02/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
BEAM THERAPEUTICS INC.	-6.72x	28.43x	-4.39x	-.--%	2.94B
LONZA GROUP AG	30.13x	5.34x	16.55x	1.09%	43.68B
REVOLUTION MEDICINES, INC.	-18.13x	265.48x	-16.35x	-.--%	30.65B
IQVIA HOLDINGS INC.	22.17x	2.55x	11.02x	-.--%	30.4B
BEONE MEDICINES AG	39.33x	3.9x	24.96x	-.--%	29.31B
CELLTRION, INC.	28.27x	7.29x	18.77x	0.42%	24.2B
MEDPACE HOLDINGS, INC.	27.34x	4.38x	19.95x	-.--%	13.3B
EUROFINS SCIENTIFIC SE	22.72x	1.96x	8.62x	1.17%	13.21B
IONIS PHARMACEUTICALS, INC.	-20.47x	13.36x	-19.89x	-.--%	12.12B
Average	13.85x	36.96x	6.58x	0.3%	22.2B
Weighted average by Cap.	18.35x	45.39x	9.35x	0.37%